IQVIA HOLDINGS INC. Effective Income Tax Rate Reconciliation Fdii Percent
IQVIA HOLDINGS INC. (IQV) reported Effective Income Tax Rate Reconciliation Fdii Percent of 3.60% for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-17.
Financial Statements › Expense Statement › Income Tax
us-gaap:EffectiveIncomeTaxRateReconciliationFdiiPercent · last filed 2026-02-17
- IQVIA HOLDINGS INC. effective income tax rate reconciliation fdii percent for fiscal 2025 was 3.60%, a 80.00% decline from fiscal 2024.
- IQVIA HOLDINGS INC. effective income tax rate reconciliation fdii percent for fiscal 2024 was 18.00%, a 160.87% increase from fiscal 2023.
- IQVIA HOLDINGS INC. effective income tax rate reconciliation fdii percent for fiscal 2023 was 6.90%, a 63.87% decline from fiscal 2022.
- IQVIA HOLDINGS INC. effective income tax rate reconciliation fdii percent for fiscal 2022 was 19.10%.
| Period end | Effective Income Tax Rate Reconciliation Fdii Percent 12 month |
|---|---|
| 2025-12-31 | 3.60% 10-K · filed 2026-02-17 |
| 2024-12-31 | 18.00% 10-K · filed 2025-02-13 |
| 2023-12-31 | 6.90% 10-K · filed 2025-02-13 |
| 2022-12-31 | 19.10% 10-K · filed 2025-02-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B |